Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-12

FDA Approved: GRANISETRON HYDROCHLORIDE — Supplemental Application (Bionpharma Inc.)

View source ↗

Summary

FDA approved a supplemental application for Granisetron Hydrochloride by Bionpharma Inc., a generic antiemetic used to prevent chemotherapy- and surgery-related…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Granisetron hydrochloride (granisetron hydrochloride)

Snippet

SUPPL AP for GRANISETRON HYDROCHLORIDE (GRANISETRON HYDROCHLORIDE)